Perioperative NT-proBNP Risk Triage Model (VISION-based)
- Perioperative NT-proBNP Risk Triage Model: Comprehensive Explanation and Clinical Context
N-terminal pro–B-type natriuretic peptide (NT-proBNP) is a cardiac biomarker that reflects myocardial wall stress and neurohormonal activation. In large perioperative cohorts, preoperative NT-proBNP provides substantial prognostic information for vascular death and myocardial injury after noncardiac surgery (MINS) within 30 days, complementing and often outperforming traditional clinical risk indices.
Original publication–based categories (VISION): Patients are triaged into four strata using preoperative NT-proBNP measured within 30 days before surgery: <100 pg/mL (Low), 100–199 pg/mL (Elevated), 200–1499 pg/mL (High), and ≥1500 pg/mL (Very High). These strata correspond to progressively higher incidences of the composite outcome (vascular death or MINS) at 30 days and higher all-cause mortality. This calculator implements those exact thresholds and published incidence estimates to provide a pragmatic, evidence-based risk estimate.
Clinical significance: Compared with patients <100 pg/mL, those with 100–<200, 200–<1500, and ≥1500 pg/mL have markedly higher adjusted hazards for vascular events. Incorporating NT-proBNP into perioperative assessment can improve risk stratification, guide shared decision-making, and inform intensity of monitoring (e.g., consideration of perioperative troponin surveillance, hemodynamic vigilance, and postoperative telemetry in high/very-high strata).
Clinical interpretation summary: Low (<100 pg/mL) suggests low biomarker-defined risk. Elevated (100–199 pg/mL) indicates nontrivial risk; ensure optimization of comorbidities and appropriate monitoring. High (200–1499 pg/mL) and Very High (≥1500 pg/mL) indicate substantial risk of perioperative vascular events; consider escalated perioperative optimization and postoperative troponin monitoring as aligned with institutional protocols. Always interpret alongside clinical context (surgical magnitude, urgency, comorbidities, and institutional pathways).
Reference:
Duceppe E, et al. Ann Intern Med. 2020;172:190–199. Preoperative NT-proBNP and cardiovascular events after noncardiac surgery (VISION study).
Paladugu S, Donato AA. Ann Intern Med. 2020;172:JC59. ACP Journal Club synopsis with category-specific event rates.
Buse GL, et al. JAMA Netw Open. 2023;6:e2342086. Validated use of VISION NT-proBNP categories and incremental value over functional capacity measures.
Schmidt G, et al. BMC Anesthesiol. 2024;24:188. Reinforces clinically applicable cut-offs in noncardiac surgery cohorts.
Discussion
No discussions yet. Be the first to comment.
Create Note
Notes are stored privately on your device only. No login required. Nothing is uploaded or shared.